These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 26272028

  • 1. A longitudinal study of cortical grey matter lesion subtypes in relapse-onset multiple sclerosis.
    Sethi V, Yousry T, Muhlert N, Tozer DJ, Altmann D, Ron M, Wheeler-Kingshott C, Miller DH, Chard DT.
    J Neurol Neurosurg Psychiatry; 2016 Jul; 87(7):750-3. PubMed ID: 26272028
    [Abstract] [Full Text] [Related]

  • 2. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C.
    Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
    [Abstract] [Full Text] [Related]

  • 3. Cortical and Subcortical Morphometric and Iron Changes in Relapsing-Remitting Multiple Sclerosis and Their Association with White Matter T2 Lesion Load : A 3-Tesla Magnetic Resonance Imaging Study.
    Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M.
    Clin Neuroradiol; 2019 Mar; 29(1):51-64. PubMed ID: 29299614
    [Abstract] [Full Text] [Related]

  • 4. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY, Vitorino RC, Hojjat SP, Mulholland AD, Zhang L, Lee L, Carroll TJ, Cantrell CG, Figley CR, Aviv RI.
    Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
    [Abstract] [Full Text] [Related]

  • 5. The role of global and regional gray matter volume decrease in multiple sclerosis.
    Grothe M, Lotze M, Langner S, Dressel A.
    J Neurol; 2016 Jun; 263(6):1137-45. PubMed ID: 27094570
    [Abstract] [Full Text] [Related]

  • 6. Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis.
    Kearney H, Miszkiel KA, Yiannakas MC, Altmann DR, Ciccarelli O, Miller DH.
    Mult Scler; 2016 Jun; 22(7):910-20. PubMed ID: 26432854
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P, Pagani E, Morelli ME, Copetti M, Martinelli V, Pirro F, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [Abstract] [Full Text] [Related]

  • 9. Juxtacortical Lesions in Multiple Sclerosis: Assessment of Gray Matter Involvement Using Phase Difference-enhanced Imaging (PADRE).
    Futatsuya K, Kakeda S, Yoneda T, Ueda I, Watanabe K, Moriya J, Murakami Y, Ide S, Ogasawara A, Ohnari N, Okada K, Adachi H, Korogi Y.
    Magn Reson Med Sci; 2016 Oct 11; 15(4):349-354. PubMed ID: 26841855
    [Abstract] [Full Text] [Related]

  • 10. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 11; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 11. Staging of cortical and deep grey matter functional connectivity changes in multiple sclerosis.
    Meijer KA, Eijlers AJC, Geurts JJG, Schoonheim MM.
    J Neurol Neurosurg Psychiatry; 2018 Feb 11; 89(2):205-210. PubMed ID: 28986469
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characteristics of lesional and extra-lesional cortical grey matter in relapsing-remitting and secondary progressive multiple sclerosis: A magnetisation transfer and diffusion tensor imaging study.
    Yaldizli Ö, Pardini M, Sethi V, Muhlert N, Liu Z, Tozer DJ, Samson RS, Wheeler-Kingshott CA, Yousry TA, Miller DH, Chard DT.
    Mult Scler; 2016 Feb 11; 22(2):150-9. PubMed ID: 26014608
    [Abstract] [Full Text] [Related]

  • 15. MS cortical lesions on DIR: not quite what they seem?
    Sethi V, Muhlert N, Ron M, Golay X, Wheeler-Kingshott CA, Miller DH, Chard DT, Yousry TA.
    PLoS One; 2013 Feb 11; 8(11):e78879. PubMed ID: 24244381
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intra- and interscanner variability of magnetic resonance imaging based volumetry in multiple sclerosis.
    Biberacher V, Schmidt P, Keshavan A, Boucard CC, Righart R, Sämann P, Preibisch C, Fröbel D, Aly L, Hemmer B, Zimmer C, Henry RG, Mühlau M.
    Neuroimage; 2016 Nov 15; 142():188-197. PubMed ID: 27431758
    [Abstract] [Full Text] [Related]

  • 19. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
    Parra Corral MA, Govindarajan ST, Stefancin P, Bangiyev L, Coyle PK, Duong TQ.
    Mult Scler Relat Disord; 2019 Jun 15; 31():74-81. PubMed ID: 30951968
    [Abstract] [Full Text] [Related]

  • 20. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ.
    Neuroimage; 2009 Mar 01; 45(1):60-7. PubMed ID: 19013533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.